HealthyNCT06868563
Nerve Conduction Studies in Amateur Football, Volleyball and Tennis Athletes
An observational study of Healthy and Volleyball Players, run by Istanbul Bilgi University at 1 site in Turkey (Türkiye).
Trial summary
The aim of the study was to determine how nerve conduction velocities in the upper and lower extremities of athletes in football, volleyball and tennis branches change. The study was completed with a total of 64 participants in 4 groups, with equal numbers of participants in the groups: football, volleyball and tennis… Read more about this study
- Who is it for?
- Ages 18 to 35 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy, Volleyball Players, Football Players
- How many people
- 64 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 May 2024to 20 Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: The study population consists of healthy adult individuals divided into four groups: sedentary individuals (control group), football players, volleyball players, and tennis players. Participants were recruited from local sports clubs, university teams, and recreational athletes. The control group consists of individuals who have not engaged in regular sports activities. All participants were assessed in a single session at a designated laboratory setting.
Who may be able to join
- Being over 18 years old and under 35 years old,
- Being willing to participate in the study,
- Signing the informed consent form,
- Athlete groups must have been actively training for at least 3 days per week and a minimum of 6 hours per week over the past year,
Who cannot join
- Being under 18 and over 35
- Having metabolic diseases that may affect nerve conduction speeds (hypothyroidism, hyperthyroidism, diabetes mellitus, etc.)
- Participants who are not suitable for EMG measurement, such as cardiac problems, skin infections, and epilepsy
- Having had a previous surgical operation on the extremity where EMG measurement will be performed
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
İstanbul Bilgi University Electroneurophysiology Laboratory
Istanbul, 34381
About this study
Official title: Motor and Sensory Nerve Conduction Studies in Amateur Football, Volleyball and Tennis Athletes
The aim of the study was to determine how nerve conduction velocities in the upper and lower extremities of athletes in football, volleyball and tennis branches change. The study was completed with a total of 64 participants in 4 groups, with equal numbers of participants in the groups: football, volleyball and tennis players, and a control group that does not do sports. Nerve conduction studies (ulnar sensory, median motor, tibial motor and sural sensory nerves) with an EMG (electromyography) device were applied to participants in 4 groups.
Read the detailed description
The nerve conduction studies in the research were conducted using a Neuro-MEP-4 branded 4-channel digital EMG/EP (electromyography/evoked potentials) device manufactured by Neurosoft. Throughout the measurements, various equipment was used, including ring electrodes, grounding electrodes, stimulation electrodes, recording electrodes, electrode fixation straps, a marker pen for marking, a measuring tape for distance measurement, ultrasound gel for conductivity, skin disinfectant and paper towels for cleaning, and a pillow for positioning. The measurements were carried out in an electroneurophysiology laboratory that provided a quiet and artifact-free isolated environment.
To facilitate the measurements, participants were requested to wear clothing that could be rolled up to the knee and elbow area. Before the measurements, it was checked whether the participants had been fasting or dehydrated for an extended period. If such a condition was detected, their hunger and dehydration were addressed to prevent nerve conduction changes due to hyponatremia. Additionally, participants were asked to remove accessories such as rings, watches, and bracelets, and electronic devices, including mobile phones, were kept outside the laboratory. If the participants had cold hands or feet, their extremities were warmed using a heater to avoid any impact on nerve conduction. Furthermore, to prevent potential risks, participants were asked whether they had a pacemaker or a history of epilepsy.
Upper extremity nerve measurements were conducted while participants were seated with pillow support, while lower extremity nerve measurements were taken with participants in supine and prone positions on the examination table. The average skin temperature was 32.2°C, ranging between 31-33°C. Participants with cold skin temperatures had their extremities warmed using an infrared heat lamp. The average room temperature was 26.3°C. All participants were tested at the same time of day in the morning to eliminate the effects of circadian rhythm, and they were advised to avoid strenuous physical activity on the test day.
For the median motor nerve conduction study, the participant was positioned on a chair with pillow support under the forearm. The participant's clothing was rolled up above the elbow, and all accessories were removed. The skin area to be measured was cleaned, and gel was applied to the recording electrode, which was then placed on the abductor pollicis brevis (APB) muscle using the belly-tendon technique. The ground electrode was placed between the stimulation and recording electrodes.
The participant was instructed to relax their muscles, and initially, a low-intensity stimulation of 10 milliampere (mA) was applied at the distal stimulation site (approximately 8 centimeter (cm) proximally from the active recording electrode, at the wrist, between the flexor carpi radialis (FCR) and palmaris longus (PL) tendons, and 2 cm proximal to the distal wrist crease) after applying gel to the stimulation electrode. The current intensity was gradually increased to a supramaximal level, and the compound muscle action potential (CMAP) response was recorded. The best response was identified, and the distal stimulation site was marked with a marker pen. The distance between the recording electrode and the distal stimulation site was measured with a measuring tape and recorded.
Next, stimulation was applied at the proximal stimulation site (at the antecubital fossa, just medial to the biceps tendon). The stimulation intensity was increased to a supramaximal level, and the CMAP response was obtained. The proximal stimulation site was also marked with a marker pen. The distance between the proximal and distal stimulation sites was measured with a measuring tape and recorded.
The latency and amplitude values of the recorded CMAP responses were automatically calculated and recorded by the EMG software. The distances measured with the measuring tape were entered into the EMG software, and the nerve conduction velocities were calculated. The measurements were performed on both the right and left extremities.
For the ulnar nerve sensory conduction study, the participant was positioned on a chair with a pillow placed under the forearm for support. The participant's clothing was rolled up to expose the area above the elbow. Accessories were removed, and the skin area to be measured was cleaned. The participant was instructed to keep their extremity relaxed while positioning the forearm in maximal supination with internal rotation of the arm.
The ulnar nerve sensory conduction study was performed using the antidromic method. Ring electrodes were placed on the 5th finger with the black electrode proximally and the red electrode distally after applying gel. The ground electrode was fixed to the palm. The stimulation electrode was positioned 11-13 cm proximally from the active recording electrode, lateral to the flexor carpi ulnaris (FCU) tendon, after applying gel. The conduction study was initiated with a low-intensity current of 2 mA, and the stimulus intensity was gradually increased until an appropriate sensory nerve action potential (SNAP) was obtained. Once a clear SNAP response was observed, stimulation was repeated 5-6 times, and averaging was performed.
Next, the stimulation site was marked with a felt-tip pen, and the distance between the active recording electrode and the stimulation point was measured with a measuring tape and recorded. The latency and amplitude data of the SNAP response obtained from averaging were recorded in the EMG software. After entering the measured distance between the stimulation and recording electrodes into the program, the sensory conduction velocity of the ulnar nerve was determined. All procedures were performed for both the right and left extremities.
For the tibial nerve motor conduction study, the participant was positioned in a supine position on the examination table. The participant was asked to roll up their clothing above the knee level, and accessories were removed. The extremity was cleaned before the procedure.
The recording electrode was placed on the abductor hallucis muscle using the belly-tendon technique with gel and was securely fixed. The ground electrode was placed in an area between the stimulation and recording electrodes. The participant was instructed to keep their muscles relaxed. For distal stimulation, the stimulator electrode was placed approximately 8 cm proximally from the active recording electrode, on the posterior side of the medial malleolus, after applying gel. An initial low-intensity stimulation of 10 mA was applied, then gradually increased to a supramaximal level. The resulting CMAP response was recorded. The distal stimulation point was marked with a felt-tip pen, and the distance between the active recording electrode and the distal stimulation site was measured with a tape measure and recorded.
For proximal stimulation, the participant's knee was positioned at a 30-45° flexion angle, and they were instructed to keep their muscles relaxed. The stimulator electrode was placed on the popliteal fossa with gel. While placing the stimulation electrode, the examiner provided support under the participant's knee to ensure muscle relaxation and obtain a good response. Due to the deep location of the nerve in this region, in muscular participants, both the stimulus intensity and duration were increased to obtain a response. The supramaximal stimulation was applied, and the resulting CMAP response was recorded.
The latency and amplitude values of the CMAP response were automatically generated in the EMG software. The proximal stimulation site was then marked with a felt-tip pen, and the distance between the proximal and distal stimulation sites was measured with a tape measure and recorded. After entering these distance values into the program, the motor conduction velocity of the tibial nerve was determined. The measurements were performed on both extremities.
For the sural nerve sensory conduction study, the participant was positioned in a prone position on the examination table, ensuring that the ankle remained free for testing. The participant was asked to roll up their clothing above the knee level, and accessories were removed. The extremity was cleaned before the procedure.
This study was performed using the antidromic method. The recording electrode was placed behind the lateral malleolus after applying gel. The ground electrode was positioned and secured between the stimulation and recording electrodes. The stimulation electrode was placed approximately 12-14 cm proximally from the active recording electrode, lateral to the midline of the calf, after applying gel.
The participant was instructed to keep their muscles relaxed, and a low-intensity stimulation of 2 mA was applied. The stimulus intensity was gradually increased until an appropriate SNAP response was obtained. Once a clear SNAP response was recorded, 5-6 additional stimulations were applied, and averaging was performed.
The latency and amplitude values of the SNAP response obtained from averaging were recorded in the EMG software. The stimulation site was then marked with a felt-tip pen, and the distance between the active recording electrode and the stimulation site was measured with a tape measure and recorded. After entering the measured distances into the program, the nerve conduction velocity of the sural nerve was determined. All procedures were performed for both extremities.
- Conditions
- Healthy, Volleyball Players, Football Players
- Keywords
- EMG, nerve conduction studies, nerve conduction velocity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Control Group | Participants in this group were selected from individuals who had not actively participated in any sports training or competition in the past year. Nerve conduction studies were performed on the ulnar sensory, median motor, tibial motor, and sural sensory nerves for both the dominant and non-dominant extremities of the participants using an EMG device. | |
| Football Group | Participants in this group were selected from athletes who have been actively engaged in sports for the past year and have participated in football training or competitions at least three times a week, for a total of at least 6 hours. Nerve conduction studies were performed on the ulnar sensory, median motor, tibial motor, and sural sensory nerves in both the dominant and non-dominant extremities of the participants using an EMG device. | |
| Volleyball Group | Participants in this group were selected from athletes who have been actively engaged in sports for the past year and have participated in volleyball training or competitions at least three times a week, for a total of at least 6 hours. Nerve conduction studies were performed on the ulnar sensory, median motor, tibial motor, and sural sensory nerves in both the dominant and non-dominant extremities of the participants using an EMG device. | |
| Tennis Group | Participants in this group were selected from athletes who have been actively engaged in sports for the past year and have participated in tennis training or competitions at least three times a week, for a total of at least 6 hours. Nerve conduction studies were performed on the ulnar sensory, median motor, tibial motor, and sural sensory nerves in both the dominant and non-dominant extremities of the participants using an EMG device. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Electromyography
It was performed with a 4-channel digital EMG/EP device, branded as Neuro-MEP-4, a Neurosoft company. Equipment such as ring electrode, grounding electrode, stimulation electrode, recording electrode, electrode fixation velcro, felt-tip pen for marking, tape measure for distance measurement, ultrasound gel for providing conductivity, skin disinfectant and paper towel for cleaning, and pillow for positioning were used throughout the measurements.
Measured: One-time assessment on the day of enrollment, approximately 1 hour per participant.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Mar 2025
- Study start15 May 2024
- Primary completion20 Dec 2024
- Study completion20 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 64 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul Bilgi University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Umut Paksoy, Istanbul Bilgi University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06868563
- Sponsor's protocol ID
- 2024/09
- Status last verified
- Mar 2025
- First submitted
- 5 Feb 2025
- Last updated
- 11 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Motor and Sensory Nerve Conduction Studies in Amateur Football, Volleyball and Tennis Athletes
- ClinicalTrials.gov ID
- NCT06868563
- Acronym / sponsor ID
- 2024/09
- Conditions
- Healthy, Volleyball Players, Football Players
- Keywords
- EMG, nerve conduction studies, nerve conduction velocity
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 64 participants (actual)
- Lead sponsor
- Istanbul Bilgi UniversityUniversity, hospital or other
- Study start
- 15 May 2024 (actual)
- Primary completion
- 20 Dec 2024 (actual)
- Study completion
- 20 Dec 2024 (actual)
- First posted
- 11 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study was to determine how nerve conduction velocities in the upper and lower extremities of athletes in football, volleyball and tennis branches change. The study was completed with a total of 64 participants in 4 groups, with equal numbers of participants in the groups: football, volleyball and tennis players, and a control group that does not do sports. Nerve conduction studies (ulnar sensory, median motor, tibial motor and sural sensory nerves) with an EMG (electromyography) device were applied to participants in 4 groups.
Detailed description
The nerve conduction studies in the research were conducted using a Neuro-MEP-4 branded 4-channel digital EMG/EP (electromyography/evoked potentials) device manufactured by Neurosoft. Throughout the measurements, various equipment was used, including ring electrodes, grounding electrodes, stimulation electrodes, recording electrodes, electrode fixation straps, a marker pen for marking, a measuring tape for distance measurement, ultrasound gel for conductivity, skin disinfectant and paper towels for cleaning, and a pillow for positioning. The measurements were carried out in an electroneurophysiology laboratory that provided a quiet and artifact-free isolated environment.
To facilitate the measurements, participants were requested to wear clothing that could be rolled up to the knee and elbow area. Before the measurements, it was checked whether the participants had been fasting or dehydrated for an extended period. If such a condition was detected, their hunger and dehydration were addressed to prevent nerve conduction changes due to hyponatremia. Additionally, participants were asked to remove accessories such as rings, watches, and bracelets, and electronic devices, including mobile phones, were kept outside the laboratory. If the participants had cold hands or feet, their extremities were warmed using a heater to avoid any impact on nerve conduction. Furthermore, to prevent potential risks, participants were asked whether they had a pacemaker or a history of epilepsy.
Upper extremity nerve measurements were conducted while participants were seated with pillow support, while lower extremity nerve measurements were taken with participants in supine and prone positions on the examination table. The average skin temperature was 32.2°C, ranging between 31-33°C. Participants with cold skin temperatures had their extremities warmed using an infrared heat lamp. The average room temperature was 26.3°C. All participants were tested at the same time of day in the morning to eliminate the effects of circadian rhythm, and they were advised to avoid strenuous physical activity on the test day.
For the median motor nerve conduction study, the participant was positioned on a chair with pillow support under the forearm. The participant's clothing was rolled up above the elbow, and all accessories were removed. The skin area to be measured was cleaned, and gel was applied to the recording electrode, which was then placed on the abductor pollicis brevis (APB) muscle using the belly-tendon technique. The ground electrode was placed between the stimulation and recording electrodes.
The participant was instructed to relax their muscles, and initially, a low-intensity stimulation of 10 milliampere (mA) was applied at the distal stimulation site (approximately 8 centimeter (cm) proximally from the active recording electrode, at the wrist, between the flexor carpi radialis (FCR) and palmaris longus (PL) tendons, and 2 cm proximal to the distal wrist crease) after applying gel to the stimulation electrode. The current intensity was gradually increased to a supramaximal level, and the compound muscle action potential (CMAP) response was recorded. The best response was identified, and the distal stimulation site was marked with a marker pen. The distance between the recording electrode and the distal stimulation site was measured with a measuring tape and recorded.
Next, stimulation was applied at the proximal stimulation site (at the antecubital fossa, just medial to the biceps tendon). The stimulation intensity was increased to a supramaximal level, and the CMAP response was obtained. The proximal stimulation site was also marked with a marker pen. The distance between the proximal and distal stimulation sites was measured with a measuring tape and recorded.
The latency and amplitude values of the recorded CMAP responses were automatically calculated and recorded by the EMG software. The distances measured with the measuring tape were entered into the EMG software, and the nerve conduction velocities were calculated. The measurements were performed on both the right and left extremities.
For the ulnar nerve sensory conduction study, the participant was positioned on a chair with a pillow placed under the forearm for support. The participant's clothing was rolled up to expose the area above the elbow. Accessories were removed, and the skin area to be measured was cleaned. The participant was instructed to keep their extremity relaxed while positioning the forearm in maximal supination with internal rotation of the arm.
The ulnar nerve sensory conduction study was performed using the antidromic method. Ring electrodes were placed on the 5th finger with the black electrode proximally and the red electrode distally after applying gel. The ground electrode was fixed to the palm. The stimulation electrode was positioned 11-13 cm proximally from the active recording electrode, lateral to the flexor carpi ulnaris (FCU) tendon, after applying gel. The conduction study was initiated with a low-intensity current of 2 mA, and the stimulus intensity was gradually increased until an appropriate sensory nerve action potential (SNAP) was obtained. Once a clear SNAP response was observed, stimulation was repeated 5-6 times, and averaging was performed.
Next, the stimulation site was marked with a felt-tip pen, and the distance between the active recording electrode and the stimulation point was measured with a measuring tape and recorded. The latency and amplitude data of the SNAP response obtained from averaging were recorded in the EMG software. After entering the measured distance between the stimulation and recording electrodes into the program, the sensory conduction velocity of the ulnar nerve was determined. All procedures were performed for both the right and left extremities.
For the tibial nerve motor conduction study, the participant was positioned in a supine position on the examination table. The participant was asked to roll up their clothing above the knee level, and accessories were removed. The extremity was cleaned before the procedure.
The recording electrode was placed on the abductor hallucis muscle using the belly-tendon technique with gel and was securely fixed. The ground electrode was placed in an area between the stimulation and recording electrodes. The participant was instructed to keep their muscles relaxed. For distal stimulation, the stimulator electrode was placed approximately 8 cm proximally from the active recording electrode, on the posterior side of the medial malleolus, after applying gel. An initial low-intensity stimulation of 10 mA was applied, then gradually increased to a supramaximal level. The resulting CMAP response was recorded. The distal stimulation point was marked with a felt-tip pen, and the distance between the active recording electrode and the distal stimulation site was measured with a tape measure and recorded.
For proximal stimulation, the participant's knee was positioned at a 30-45° flexion angle, and they were instructed to keep their muscles relaxed. The stimulator electrode was placed on the popliteal fossa with gel. While placing the stimulation electrode, the examiner provided support under the participant's knee to ensure muscle relaxation and obtain a good response. Due to the deep location of the nerve in this region, in muscular participants, both the stimulus intensity and duration were increased to obtain a response. The supramaximal stimulation was applied, and the resulting CMAP response was recorded.
The latency and amplitude values of the CMAP response were automatically generated in the EMG software. The proximal stimulation site was then marked with a felt-tip pen, and the distance between the proximal and distal stimulation sites was measured with a tape measure and recorded. After entering these distance values into the program, the motor conduction velocity of the tibial nerve was determined. The measurements were performed on both extremities.
For the sural nerve sensory conduction study, the participant was positioned in a prone position on the examination table, ensuring that the ankle remained free for testing. The participant was asked to roll up their clothing above the knee level, and accessories were removed. The extremity was cleaned before the procedure.
This study was performed using the antidromic method. The recording electrode was placed behind the lateral malleolus after applying gel. The ground electrode was positioned and secured between the stimulation and recording electrodes. The stimulation electrode was placed approximately 12-14 cm proximally from the active recording electrode, lateral to the midline of the calf, after applying gel.
The participant was instructed to keep their muscles relaxed, and a low-intensity stimulation of 2 mA was applied. The stimulus intensity was gradually increased until an appropriate SNAP response was obtained. Once a clear SNAP response was recorded, 5-6 additional stimulations were applied, and averaging was performed.
The latency and amplitude values of the SNAP response obtained from averaging were recorded in the EMG software. The stimulation site was then marked with a felt-tip pen, and the distance between the active recording electrode and the stimulation site was measured with a tape measure and recorded. After entering the measured distances into the program, the nerve conduction velocity of the sural nerve was determined. All procedures were performed for both extremities.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Control Group | – | –Participants in this group were selected from individuals who had not actively participated in any sports training or competition in the past year. Nerve conduction studies were performed on the ulnar sensory, median motor, tibial motor, and sural sensory nerves for both the dominant and non-dominant extremities of the participants using an EMG device. |
| Football Group | – | –Participants in this group were selected from athletes who have been actively engaged in sports for the past year and have participated in football training or competitions at least three times a week, for a total of at least 6 hours. Nerve conduction studies were performed on the ulnar sensory, median motor, tibial motor, and sural sensory nerves in both the dominant and non-dominant extremities of the participants using an EMG device. |
| Volleyball Group | – | –Participants in this group were selected from athletes who have been actively engaged in sports for the past year and have participated in volleyball training or competitions at least three times a week, for a total of at least 6 hours. Nerve conduction studies were performed on the ulnar sensory, median motor, tibial motor, and sural sensory nerves in both the dominant and non-dominant extremities of the participants using an EMG device. |
| Tennis Group | – | –Participants in this group were selected from athletes who have been actively engaged in sports for the past year and have participated in tennis training or competitions at least three times a week, for a total of at least 6 hours. Nerve conduction studies were performed on the ulnar sensory, median motor, tibial motor, and sural sensory nerves in both the dominant and non-dominant extremities of the participants using an EMG device. |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- The study population consists of healthy adult individuals divided into four groups: sedentary individuals (control group), football players, volleyball players, and tennis players. Participants were recruited from local sports clubs, university teams, and recreational athletes. The control group consists of individuals who have not engaged in regular sports activities. All participants were assessed in a single session at a designated laboratory setting.
Key inclusion criteria (4 listed)
- Being over 18 years old and under 35 years old,
- Being willing to participate in the study,
- Signing the informed consent form,
- Athlete groups must have been actively training for at least 3 days per week and a minimum of 6 hours per week over the past year,
Key exclusion criteria (4 listed)
- Being under 18 and over 35
- Having metabolic diseases that may affect nerve conduction speeds (hypothyroidism, hyperthyroidism, diabetes mellitus, etc.)
- Participants who are not suitable for EMG measurement, such as cardiac problems, skin infections, and epilepsy
- Having had a previous surgical operation on the extremity where EMG measurement will be performed
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Electromyography
Time frame: One-time assessment on the day of enrollment, approximately 1 hour per participant.
It was performed with a 4-channel digital EMG/EP device, branded as Neuro-MEP-4, a Neurosoft company. Equipment such as ring electrode, grounding electrode, stimulation electrode, recording electrode, electrode fixation velcro, felt-tip pen for marking, tape measure for distance measurement, ultrasound gel for providing conductivity, skin disinfectant and paper towel for cleaning, and pillow for positioning were used throughout the measurements.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Mar 2025.
- Individual participant dataSharing planned: No
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy and Volleyball Players, run by Istanbul Bilgi University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Electromyography (time frame: One-time assessment on the day of enrollment, approximately 1 hour per participant.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2025.